Last reviewed · How we verify
Bimatoprost 0.03%, Travoprost 0.004%
Bimatoprost 0.03%, Travoprost 0.004% is a Small molecule drug developed by Innovative Medical. It is currently FDA-approved.
At a glance
| Generic name | Bimatoprost 0.03%, Travoprost 0.004% |
|---|---|
| Sponsor | Innovative Medical |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma (PHASE4)
- Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% (PHASE4)
- Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues (PHASE4)
- Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves (PHASE4)
- Safety and Efficacy of Changing to DuoTrav From Prior Therapy (PHASE4)
- The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye (PHASE4)
- Efficacy of Changing to DUOTRAV® From Prior Therapy (PHASE4)
- Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bimatoprost 0.03%, Travoprost 0.004% CI brief — competitive landscape report
- Bimatoprost 0.03%, Travoprost 0.004% updates RSS · CI watch RSS
- Innovative Medical portfolio CI
Frequently asked questions about Bimatoprost 0.03%, Travoprost 0.004%
What is Bimatoprost 0.03%, Travoprost 0.004%?
Bimatoprost 0.03%, Travoprost 0.004% is a Small molecule drug developed by Innovative Medical.
Who makes Bimatoprost 0.03%, Travoprost 0.004%?
Bimatoprost 0.03%, Travoprost 0.004% is developed and marketed by Innovative Medical (see full Innovative Medical pipeline at /company/innovative-medical).
What development phase is Bimatoprost 0.03%, Travoprost 0.004% in?
Bimatoprost 0.03%, Travoprost 0.004% is FDA-approved (marketed).